11/14/2024
4:46 PM | Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
3:32 PM | Atlas Venture Fund XI, L.P. (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
9:28 AM | Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
11/14/2024
8:27 AM | Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
6:00 AM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:34 AM | Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
11/12/2024
8:55 AM | Dyne Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
|
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
9:20 AM | Dyne Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
10/03/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:51 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:52 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:52 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:20 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:21 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:23 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:24 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:36 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:26 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:28 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:31 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:34 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:13 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:13 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:13 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:05 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:22 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:34 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:42 PM | Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:14 PM | Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
5:16 PM | Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:20 PM | Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
5:22 PM | Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:16 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The only candlestick pattern worth a darn (Ad) It’s widely known that 80% of daily market action is driven by Wall Street algorithms…
Now, most people think of the algorithms are “bad”
When in reality, they are neither good nor bad…
They are simply programmed to buy and sell certain stocks over and over again…
But here is the thing…
They are predictable…
They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… |
08/22/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:28 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:13 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:08 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:10 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:11 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:12 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:05 PM | Dyne Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
3:37 PM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
8:00 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4/A | |
06/24/2024
7:41 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:45 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:41 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:42 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:28 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:34 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:34 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:32 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:33 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:36 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Lubner David Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
HURWITZ EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Stehman-Breen Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
8:01 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:30 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
05/22/2024
6:59 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
5:00 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
3:24 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
05/20/2024
6:37 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
8:03 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:04 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:05 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:06 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:07 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:28 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:25 PM | Dyne Therapeutics (Filer)
| Form ARS | |
04/05/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
3:20 PM | Dyne Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
8:06 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
8:07 PM | Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 3/A | |
04/04/2024
6:04 PM | Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
The only candlestick pattern worth a darn (Ad) It’s widely known that 80% of daily market action is driven by Wall Street algorithms…
Now, most people think of the algorithms are “bad”
When in reality, they are neither good nor bad…
They are simply programmed to buy and sell certain stocks over and over again…
But here is the thing…
They are predictable…
They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… |
04/04/2024
3:22 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
3:24 PM | Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:24 PM | Cox John (Reporting)
Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:39 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:56 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:57 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:58 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
